OLIVIA TAYLOR: Open Payments
NPI 1255888475 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 8 companies in 2025. Trend: 2023 $51 · 2024 $254 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| Biogen, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
Products named: FANAPT, UZEDY, VRAYLAR, ZURZUVAE, CAPLYTA, ABILIFY ASIMTUFII, COBENFY, ARISTADA.
Industry payments across IN — which companies pay providers there.
